Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

As a group, these new medications are commonly referred to as "biologics" and represent the most current attempt to target specific steps in the immune mechanisms underlying psoriasis. It is the ...

Do newer types of biologics increase the risk of MACE and VTE more than older TNFs in patients with psoriasis or psoriatic arthritis? Share on Facebook. Opens in a new tab or window Share on Bluesky.

Biologics (injectables) target specific immune pathways driving psoriasis and effectively clear skin and prevent long-term inflammation. “Given the options, the current mindset is we treat to ...

Based on the immunopathology of psoriasis, we have proposed a model for biologic therapeutic approaches that identifies four mechanistic strategies. [25] A host of targeted immunologic ...

Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasisTop-line data from the 12-week double-blind ...

The approvals add two more options for psoriasis patients hoping to stay away from biologics as long as they can. If symptoms remain mild to moderate, patients can stay on these drugs indefinitely.

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasis Top-line data from the 12-week double-blind trial expected by year-end 2025 Phase 1b trial designe ...

J&J is hoping to show that the peptide drug can be a more patient-friendly alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23, such as J&J's own Tremfya ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Generalized Pustular Psoriasis (GPP) market is driven by the increasing adoption of non-invasive and minimally invasive treatment options such as topical biologic therapy, phototherapy, and laser ...